Showing results (1171-1180 of 1,195) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|September 25, 2023
Evaluating hybrid controls methodology in early-phase oncology trials: A simulation study based on the MORPHEUS-UC trialGuanbo Wang, Melanie Poulin-Costello, Herbert Pang, et al.Pharmaceutical Statistics|September 17, 2023
A marginalized two-part joint model for a longitudinal biomarker and a terminal event with application to advanced head and neck cancersDenis Rustand, Laurent Briollais, Virginie RondeauPharmaceutical Statistics|March 9, 2026
"Within-Trial" Prognostic Score Adjustment Is Targeted Maximum Likelihood EstimationEmilie Højbjerre-Frandsen, Alejandro SchulerPharmaceutical Statistics|February 19, 2026
Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification BiasSihan Jia, Shirui Wang, Gengsheng QinPharmaceutical Statistics|April 19, 2026
RABOTS: A Randomized Adaptive Bayesian Optimization Two-Stage Seamless Design for Dose Optimization and Proof-of-Concept EvaluationXiaochen Zhu, Yiwei Li, Jiaju Wu, et al.Pharmaceutical Statistics|April 6, 2026
Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects ModelXinru Ren, Jin XuPharmaceutical Statistics|May 10, 2026
An Ensemble Classifier for Ordinal Outcomes in High-Dimensional Genomics DataHeranga K Rathnasekara, Sinjini SikdarPharmaceutical Statistics|March 16, 2021
Decomposition analysis as a framework for understanding heterogeneity of treatment effects in non-randomized health care studiesWilliam H CrownPharmaceutical Statistics|August 4, 2021
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpointsVaiva Deltuvaite-Thomas, Tomasz BurzykowskiPharmaceutical Statistics|November 2, 2022
On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomesMickaël De Backer, Catherine Legrand, Julien Péron, et al.Pageof 120